Wong Limy, Counihan Aileen, O'Kelly Patrick, Sexton Donal J, O'Seaghdha Conall M, Magee Colm, Little Dilly, Conlon Peter J
Department of Nephrology and Transplantation, Beaumont Hospital, Dublin 9, Ireland.
Department of Transplantation and Urology, Beaumont Hospital, Dublin, Ireland.
Int Urol Nephrol. 2018 Mar;50(3):551-558. doi: 10.1007/s11255-017-1745-1. Epub 2017 Nov 14.
Donor/recipient size mismatching and correlation to allograft outcome remains poorly defined. This study assessed the impact of donor body weight (DBW) to recipient body weight (RBW) ratio on allograft function and survival.
A total of 898 deceased donor renal transplant recipients were included in the study. Patients were divided into quartiles depending on the ratio of DBW/RBW: Q1 (≤ 0.88), Q2 (0.89-1.00), Q3 (1.01-1.22) and Q4 (> 1.22). Donor and recipient characteristics were obtained from the national kidney transplant service database. Serum creatinine and estimated glomerular filtration rate (eGFR) at 1 and 5 years after transplant were compared.
Q4 patients had a higher eGFR 1 year post-transplant (median 59.5 ml/min, IQR 46.8-76.2) compared to Q1-Q3 which had median eGFRs of 54.3, 54.8 and 55.3 ml/min, respectively (p < 0.001). At 5 years post-transplant, there were modest differences in the eGFR across the four quartiles, Q1-4 with median eGFRs of 56.9, 61.1, 61.2 and 58.6 ml/min, respectively (p = 0.02). However, there were no significant differences in 1- and 5-year allograft survival between groups.
In the setting of deceased donor renal transplantation, mismatching of donor to recipient weight had no impact on 5-year allograft survival, but a low DBW/RBW ratio is modestly associated with lower eGFR.
供体/受体大小不匹配及其与同种异体移植结果的相关性仍未明确界定。本研究评估了供体体重(DBW)与受体体重(RBW)之比对同种异体移植功能和存活的影响。
本研究共纳入898例已故供体肾移植受者。根据DBW/RBW之比将患者分为四分位数:Q1(≤0.88)、Q2(0.89 - 1.00)、Q3(1.01 - 1.22)和Q4(>1.22)。供体和受体特征来自国家肾脏移植服务数据库。比较移植后1年和5年的血清肌酐和估计肾小球滤过率(eGFR)。
与Q1 - Q3相比,Q4患者移植后1年的eGFR更高(中位数59.5 ml/min,四分位间距46.8 - 76.2),Q1 - Q3的eGFR中位数分别为54.3、54.8和55.3 ml/min(p < 0.001)。移植后5年,四个四分位数的eGFR存在适度差异,Q1 - 4的eGFR中位数分别为56.9、61.1、61.2和58.6 ml/min(p = 0.02)。然而,各组之间1年和5年的同种异体移植存活率无显著差异。
在已故供体肾移植中,供体与受体体重不匹配对5年同种异体移植存活率无影响,但DBW/RBW比值较低与较低的eGFR适度相关。